Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJaywing Regulatory News (JWNG)

  • There is currently no data for JWNG

Directorate Change

21 Apr 2021 15:03

RNS Number : 2067W
Jaywing PLC
21 April 2021
ย 

ย 21 April 2021

Jaywing plc ("Jaywing")

ย ("Jaywing", "the Company" or "the Group")

Directorate Changeย 

Further to the Company's recent appointment of Caroline Ackroyd as Chief Financial Officer, Jaywing is pleased to announce that Caroline has joined the board with immediate effect.

As previously announced, Caroline is an experienced CFO with significant commercial experience in technology-based businesses operating in competitive and client-centric markets. She was previously CFO of Push Doctor, a provider of online GP services, and has held senior finance roles in Sky Betting & Gaming and Coral Interactive.

Further information to be disclosed pursuant to Schedule 2, paragraph (g) of the AIM Rules:

ย 

Caroline Ackroyd, aged 43, is currently or has previously been director of the following companies within the past five years.ย 

ย 

Push Dr Limited*

Alphanumeric Limited

Scope Creative Marketing Limited

ย 

*indicates previous directorship

Save as disclosed above, there is no further information required to be disclosed pursuant to Schedule 2, paragraph (g) of the AIM Rules.

ย 

Enquiries

ย 

Jaywing plcย (www.jaywingplc.com)

Andrew Fryatt (Chief Executive Officer)

Tel: 0114 281 1200

Cenkos Securities plc

Nicholas Wells/Callum Davidson (Nominated Adviser)

Tel: 0207 397 8900

ย 

ย 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ย 
END
ย 
ย 
BOAEALLFAEFFEFA
Date   Source Headline
13th Feb 20257:00 amRNSCancellation - Jaywing Plc
5th Feb 202510:39 amRNSResult of GM, Cancellation of Admission to Trading
21st Jan 20254:18 pmRNSCircular Amendment
14th Jan 20257:00 amRNSHolding(s) in Company
10th Jan 20257:00 amRNSPublication of Circular and Notice of GM
23rd Dec 20243:02 pmRNSNotice of Requisition of General Meeting
19th Dec 20247:00 amRNSInterim Results
3rd Dec 20247:00 amRNSChange of Registered Office
7th Oct 20247:00 amRNSIncrease in Loan Facility
1st Oct 20247:00 amRNSTrading update and further funding
26th Sep 20242:42 pmRNSResult of AGM
4th Sep 20244:59 pmRNSHolding(s) in Company
3rd Sep 20247:00 amRNSDirector/PDMR Shareholding
30th Aug 20247:00 amRNSFinal Results
31st Jul 20241:58 pmRNSStatement regarding share price movement
21st Jun 202412:01 pmRNSUpdate on Loan Facility
28th May 20245:38 pmRNSIncrease in Loan Facility
13th May 20247:00 amRNSBoard, Trading Update, Strategic Review Conclusion
3rd Apr 202411:04 amRNSBoard Appointments
26th Mar 20241:57 pmRNSForm 8.3 - Jaywing PLC
18th Mar 20245:39 pmRNSForm 8.3 - Jaywing Plc
18th Mar 20245:31 pmRNSForm 8.3 - Jaywing plc
18th Mar 20242:02 pmRNSForm 8.3 - Jaywing plc
15th Mar 20244:45 pmRNSForm 8.3 - Jaywing Plc
15th Mar 20244:21 pmRNSForm 8.3 - Jaywing plc
14th Mar 20245:43 pmRNSForm 8.3 - Jaywing plc
14th Mar 20244:14 pmRNSForm 8.3 - Jaywing Plc
14th Mar 20241:53 pmRNSForm 8.3 - Jaywing PLC
7th Mar 20243:00 pmRNSForm 8
6th Mar 202411:09 amRNSForm 8.3 - Jaywing PLC
4th Mar 20243:56 pmRNSForm 8.3 - Jaywing plc
4th Mar 20249:25 amRNS2.9 Announcement
4th Mar 20247:00 amRNSTrading update, Loan Facility and Strategic Review
21st Dec 20237:00 amRNSHalf-year Report
20th Oct 20237:00 amRNSAppointment of Nominated Adviser and Broker
28th Sep 20234:28 pmRNSResult of AGM
7th Sep 20237:00 amRNSFinal Results
13th Apr 20237:00 amRNSGrant of Share Options
16th Feb 20237:00 amRNSTrading Update
14th Feb 202311:37 amRNSAIM Rule 17 Notification
5th Jan 20233:57 pmRNSHolding(s) in Company
1st Dec 20226:11 pmRNSDirector/PDMR Shareholding
1st Dec 20227:00 amRNSHalf-year Report
11th Nov 202212:42 pmRNSHolding(s) in Company
8th Nov 20222:29 pmRNSHolding(s) in Company
8th Nov 202210:50 amRNSHolding(s) in Company
8th Nov 202210:50 amRNSHolding(s) in Company
29th Sep 20223:49 pmRNSResult of AGM
6th Sep 20222:01 pmRNSFinal Results
26th Aug 202211:59 amRNSAcquisition of Midisi Limited (replacement)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.